Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration

Estimated reading time: 1 minute

Armstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories across 7 countries in Asia, has signed a Memorandum of Understanding (MOU) with Checkmate Capital Group, LLC (“Checkmate Capital”), a U.S.-based investment and advisory firm active in the Asia-Pacific and North American regions, focused on cross-border transactions in the life sciences, medical technology, and other industries.

The MOU marks the beginning of a formal relationship between the two companies, following Armstrong’s successful collaboration with NeuroSigma, Inc (“NeuroSigma”), a Los Angeles-based bioelectronics company and a portfolio company of Checkmate Capital. Armstrong has supported NeuroSigma in building efficient and scalable supply chains for its products.

This agreement will serve as a platform for Armstrong and Checkmate Capital to explore additional areas of collaboration, particularly in the evolving medical device industry.

Ms. Phyllis Ong, Group CEO of Armstrong Asia, said: “This MOU reflects our ongoing efforts to expand Armstrong’s contribution to the medical device industry by building strategic relationships. Our work with NeuroSigma demonstrated the value of combining advanced engineering capabilities with responsive supply chain solutions, and we are pleased to take this next step with Checkmate Capital Group.”

Mr. C. Thomas Paschall, CEO of Checkmate Capital Group, commented: “We are pleased to formalise our relationship with Armstrong Asia. Armstrong’s support of NeuroSigma’s supply chain needs has demonstrated the strong capabilities and reliability they bring to the table. We look forward to exploring additional opportunities to work together in the future.”

This partnership supports Armstrong’s long-term vision of becoming a world-class manufacturing gateway that enables smarter, safer, and greener innovation through trusted partnerships.